Hydrogen sulfide and translational medicine

Acta Pharmacologica Sinica

Volumn 34, Issue 10, 2013, Pages 1284-1291

  Guo, Wei ^a   Cheng, Ze Yu ^a   Zhu, Yi Zhun ^a,b,c  

^a School of Pharmacy   (China)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antioxidant; Calcium channel; Cytochrome oxidase; H2S donor; H2S releasing drug; Hydrogen sulfide; KATP channel; NF B; Translational medicine; TRPA1

Indexed keywords

ACETYLSALICYLIC ACID; ATB 337; ATB 346; ATB 429; CALCIUM CHANNEL T TYPE; CLAMIKALANT; CYTOCHROME C OXIDASE; DICLOFENAC; GLIBENCLAMIDE; HYDROGEN SULFIDE; IODORESINIFERATOXIN; N (4 ISOPROPYLPHENYL) 2 (1,2,3,6 TETRAHYDRO 1,3 DIMETHYL 2,6 DIOXO 7H PURIN 7 YL)ACETAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; S PROPARGYLCYSTEINE; SULFORAPHANE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1 ANTAGONIST;

ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ATHEROSCLEROSIS; DOWN SYNDROME; ENDOTOXEMIA; GASTROINTESTINAL TOXICITY; HUMAN; MEDICINE; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVIEW; SEPSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; TRANSLATIONAL MEDICINE; VASODILATATION;

ANIMALS; APOPTOSIS; DRUG DESIGN; HOMEOSTASIS; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84887335619     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2013.127     Document Type: Review

References (81)

1. Li L, Hsu A, Moore PK. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation - a tale of three gases! Pharmacol Ther 2009; 123: 386-400.
2. Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, Bouillaud F. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta 2010; 1797: 1500-11.
3. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066-71. (Pubitemid 26140863)
4. Olson KR. Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? Biochim Biophys Acta 2009; 1787: 856-63.
5. Predmore BL, Lefer DJ. Development of hydrogen sulfide-based therapeutics for cardiovascular disease. J Cardiovasc Translation Res 2010; 3: 487-98.
6. Gong QH, Wang Q, Pan LL, Liu XH, Xin H, Zhu YZ. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-kappaB pathway in rats. Brain, behavior, and immunity 2011; 25: 110-9.
7. Kawabata A, Ishiki T, Nagasawa K, Yoshida S, Maeda Y, Takahashi T, et al. Hydrogen sulfide as a novel nociceptive messenger. Pain 2007; 132: 74-81. (Pubitemid 47494563)
8. Wang R. Signaling pathways for the vascular effects of hydrogen sulfide. Curr Opin Nephrol Hypertens 2011; 20: 107-12.
9. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids 2011; 41: 113-21.
10. Hughes MN, Centelles MN, Moore KP. Making and working with hydrogen sulfide: the chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med 2009; 47: 1346-53.
11. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxidants Redox Signaling 2009; 11: 205-14.
12. Cunha TM, Dal-Secco D, Verri WA Jr, Guerrero AT, Souza GR, Vieira SM, et al. Dual role of hydrogen sulfide in mechanical inflammatory hypernociception. Eur J Pharmacol 2008; 590: 127-35.
13. Liu YY, Sparatore A, Del Soldato P, Bian JS. ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid β-induced cell cytotoxicity. Neurochem Int 2011; 58: 591-8.
14. Qu K, Lee S, Bian J, Low CM, Wong PH. Hydrogen sulfide: neuro-chemistry and neurobiology. Neurochem Int 2008; 52: 155-65.
15. Whiteman M, Winyard PG. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol 2011; 4: 13-32. doi: 10.1586/ecp.10.134.
16. Tan BH, Wong PTH, Bian JS. Hydrogen sulfide: A novel signaling molecule in the central nervous system. Neurochem Int 2010; 56: 3-10.
17. Ufnal M, Sikora M, Dudek M. Exogenous hydrogen sulfide produces hemodynamic effects by triggering central neuroregulatory mechanisms. Acta Neurobiol 2008; 68: 382-8.
18. Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y, Zhu YC. The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antioxidants Redox Signaling 2010; 12: 1065-77.
19. Rossoni G, Manfredi B, Tazzari V, Sparatore A, Trivulzio S, Del Soldato P, et al. Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. Eur J Pharmacol 2010; 648: 139-45.
20. 2S): A new antihypertensive drug? Med Hypothesis 2009; 73: 445-47.
21. Perna AF, Luciano MG, Ingrosso D, Raiola I, Pulzella P, Sepe I, et al. Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients. J Renal Nutr 2010; 20: S11-S14.
22. Sowmya S, Swathi Y, Yeo AL, Shoon ML, Moore PK, Bhatia M. Hydrogen sulfide: regulatory role on blood pressure in hyperhomocysteinemia. Vasc Pharmacol 2010; 53: 138-43.
23. Zhong G, Chen F, Cheng Y, Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 2003; 21: 1879-85. (Pubitemid 37290106)
24. Qiao W, Chaoshu T, Hongfang J, Junbao D. Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun 2010; 396: 182-6.
25. Li W, Tang C, Jin H, Du J. Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats. Atherosclerosis 2011; 215: 323-30.
26. Szabó G, Veres G, Radovits T, Gero{double acute} D, Módis K, Miesel-Gröschel C, et al. Cardioprotective effects of hydrogen sulfide. Nitric Oxide 2011; 25: 201-10.
27. Ji Y, Pang Qf, Xu G, Wang L, Wang JK, Zeng YM. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol 2008; 587: 1-7.
28. Nicholson CK, Calvert JW. Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol Res 2010; 62: 289-97.
29. Fu Z, Liu X, Geng B, Fang L, Tang C. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci 2008; 82: 1196-202.
30. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, et al. Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg 2009; 138: 977-84.
31. Gao Y, Yao X, Zhang Y, Li W, Kang K, Sun L, et al. The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. Int J Cardiol 2011; 152: 177-83.
32. Chunyu Z, Junbao D, Dingfang B, Hui Y, Xiuying T, Chaoshu T. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-6.
33. Tang C, Li X, Du J. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 2006; 4: 17-22. (Pubitemid 46785178)
34. Hongfang J, Bailin C, Bin Z, Chunyu Z, Xinmin L, Weijin Z, et al. Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling. Life Sci 2006; 78: 1299-309. (Pubitemid 43199950)
35. 2S in the gastrointestinal tract still in search of a physiologic function. Antioxidants Redox Signaling 2010; 12: 1135-46.
36. Ganster F, Burban M, de la Bourdonnaye M, Fizanne L, Douay O, Loufrani L, et al. Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care 2010; 14: R165.
37. Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 2007; 28: 501-5. (Pubitemid 47488507)
38. Wallace JL, Vong L, McKnight W, Dicay M, Martin GR. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology 2009; 137: 569-78.
39. Chávez-Piña AE, Tapia-Álvarez GR, Navarrete A. Inhibition of endogenous hydrogen sulfide synthesis by PAG protects against ethanol-induced gastric damage in the rat. Eur J Pharmacol 2010; 630: 131-6.
40. Zins KA, Ordog T, Bardsley MR, Farrugia G, Levitt MD, Slungaard A, et al. T2049 hydrogen sulfide ameliorates murine experimental colitis through specific effects on diverse classes of infiltrating immune cells. Gastroenterology 2010; 138: S-621.
41. Tamizhselvi R, Koh YH, Sun J, Zhang H, Bhatia M. Hydrogen sulfide induces ICAM-1 expression and neutrophil adhesion to caerulein-treated pancreatic acinar cells through NF-κB and Src-family kinases pathway. Exp Cell Res 2010; 316: 1625-36.
42. Morselli-Labate AM, Fantini L, Pezzilli R. Hydrogen sulfide, nitric oxide and a molecular mass 66 u substance in the exhaled breath of chronic pancreatitis patients. Pancreatology 2007; 7: 497-504. (Pubitemid 47587629)
43. Bhatia M, Sidhapuriwala J. M1829 proinflammatory effects of hydrogen sulfide on substance P in caerulein-induced acute pancreatitis. Gastroenterology 2008; 134: A-428.
44. Wee EWL, Bhatia M, Fernandes ML, Madhavan K, Wong JY, Yeo AL, et al. T1301 serum hydrogen sulfide and substance P are early clinical predictors of the severity of acute pancreatitis. Gastroenterology 2009; 136: A-543.
45. Tay AS, Hu LF, Lu M, Wong PT, Bian JS. Hydrogen sulfide protects neurons against hypoxic injury via stimulation of ATP-sensitive potassium channel/protein kinase C/extracellular signal-regulated kinase/heat shock protein 90 pathway. Neuroscience 2010; 167: 277-86.
46. 2. J Phys Chem B 2006; 110: 10771-8. (Pubitemid 43952876)
47. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59 : 4-24.
48. Sun WH, Liu F, Chen Y, Zhu YC. Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochem Biophys Res Commun 2012; 421: 164-9.
49. Maeda Y, Aoki Y, Sekiguchi F, Matsunami M, Takahashi T, Nishikawa H, et al. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels. Pain 2009; 142: 127-32.
50. Okubo K, Takahashi T, Sekiguchi F, Kanaoka D, Matsunami M, Ohkubo T, et al. Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats. Neuroscience 2011; 188: 148-56.
51. Takahashi T, Aoki Y, Okubo K, Maeda Y, Sekiguchi F, Mitani K, et al. Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain. Pain 2010; 150: 183-91.
52. 2+ signalling in human vascular endothelial cells by hydrogen sulfide. Atherosclerosis 2010; 209: 374-80.
53. Matsunami M, Kirishi S, Okui T, Kawabata A. Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels. Neuroscience 2011; 181: 257-64.
54. MC M. Editorial comment on distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 2008; 53: 399-400.
55. Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, et al. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder [Research Support, Non-US Gov't]. Eur Urol 2008; 53: 391-9.
56. Miyamoto R, Otsuguro K, Ito S. Time- and concentration-dependent activation of TRPA1 by hydrogen sulfide in rat DRG neurons. Neurosci Lett 2011; 499: 137-42.
57. Chattopadhyay M, Kodela R, Nath N, Barsegian A, Boring D, Kashfi K. Hydrogen sulfide-releasing aspirin suppresses NF-kappaB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochem Pharmacol 2012; 83: 723-32.
58. Tamizhselvi R, Koh YH, Sun J, Zhang H, Bhatia M. Hydrogen sulfide induces ICAM-1 expression and neutrophil adhesion to caerulein-treated pancreatic acinar cells through NF-kappaB and Src-family kinases pathway. Exp Cell Res 2010; 316: 1625-36.
59. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, et al. Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions. Mol Cell 2012; 45: 13-24.
60. Caro A, Kauffman T, Tackett J, Thompson S. Increased oxidative stress and cytotoxicity by hydrogen sulfide in HepG2 cells overexpressing CYP2E1. Cell Biol Toxicol 2011; 27: 439-53.
61. Forgan LG, Forster ME. Oxygen consumption, ventilation frequency and cytochrome c oxidase activity in blue cod (Parapercis colias) exposed to hydrogen sulphide or isoeugenol. Comp Biochem Physiol Toxicol Pharmacol: CBP 2010; 151: 57-65.
62. Baumgart K, Radermacher P, Wagner F. Applying gases for microcirculatory and cellular oxygenation in sepsis: effects of nitric oxide, carbon monoxide, and hydrogen sulfide. Curr Opin Anaesthesiol 2009; 22: 168-76.
63. Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C. Bench-to-bedside review: hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care 2009; 13: 213.
64. Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, Pagliaro P. Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Biophys Acta 2009; 1787: 864-72.
65. Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med 2009; 13: 488-507.
66. Qu K, Lee SW, Bian JS, Low CM, Wong PT. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 2008; 52: 155-65. (Pubitemid 350235691)
67. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids 2011; 41: 113-21.
68. Zhang F, Li X, Stella C, Chen L, Liao Y, Tang C, et al. Plasma hydrogen sulfide in differential diagnosis between vasovagal syncope and postural orthostatic tachycardia syndrome in children. J Pediatrics 2012; 160: 227-31.
69. Yang J, Zhao J, Du S, Liu D, Fu C, Li X, et al. Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride. J Pediatr 2013. doi: 10.1016/j.jpeds.2013.04.039.
70. 2S-releasing drugs as pharmaceuticals. J Med Chem 2010; 53: 6275-86.
71. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxidants Redox Signal 2009; 11: 205-14.
72. Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, et al. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PloS One 2011; 6: e21077.
73. Zhao Y, Wang H, Xian M. Cysteine-activated hydrogen sulfide (H2S) donors. J Am Chem Soc 2011; 133: 15-7.
74. Chattopadhyay M, Kodela R, Nath N, Dastagirzada YM, Velazquez-Martinez CA, Boring D, et al. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochem Pharmacol 2012; 83: 715-22.
75. Chattopadhyay M, Kodela R, Olson KR, Kashfi K. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. Biochem Biophys Res Commun 2012; 419: 523-8.
76. Jacob C, Anwar A, Burkholz T. Perspective on recent developments on sulfur-containing agents and hydrogen sulfide signaling. Planta Med 2008; 74: 1580-92.
77. Sueyoshi T, Green WD, Vinal K, Woodrum TS, Moore R, Negishi M. Garlic extract diallyl sulfide (DAS) activates nuclear receptor car to induce the sult1e1 gene in mouse liver. PLoS One 2011; 6: e21229.
78. Bonaventura J, Rodriguez EN, Beyley V, Vega IE. Allylation of intraerythrocytic hemoglobin by raw garlic extracts. J Med Food 2010; 13: 943-9.
79. Sidhapuriwala JN, Hegde A, Ang AD, Zhu YZ, Bhatia M. Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice. Plos One 2012; 7: e32574.
80. Pei Y, Wu B, Cao Q, Wu L, Yang G. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells. Toxicol Appl Pharmacol 2011; 257: 420-8.
81. Gong QH, Shi XR, Hong ZY, Pan LL, Liu XH, Zhu YZ. A new hope for neurodegeneration: possible role of hydrogen sulfide. J Alzheimers Dis 2011; 24: 173-82.